New malaria vaccine tested on hundreds of african children
NCT ID NCT05155579
Summary
This study tested the safety and immune response of a new malaria vaccine called R21/Matrix-M in nearly 600 young children in Mali. Researchers compared different ways of preparing and scheduling the vaccine, and checked if it was safe to give alongside other standard childhood shots. The main goal was to see if the vaccine was safe and if it triggered a good immune response in children living in an area where malaria is common.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CCVTM, University of Oxford
Oxford, United Kingdom
-
Malaria Research & Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Medicine, Pharmacy and Dentistry, University of Sciences Techniques and Technologies of Bamako
Bamako, Mali
Conditions
Explore the condition pages connected to this study.